20 June 2018
News and Views
Links and Services
April's issue of the Inflammatory Bowel Diseases examines the incidence, clinical characteristics, and management of psoriasis induced by anti-TNF therapy in patients with inflammatory bowel disease.
Psoriasis induced by anti–tumor necrosis factor-α (TNF) therapy has been described
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors